G. Kees Hovingh
G Kees Hovingh (1974) received his medical degree at the Univerity of Groningen in 2000, his PhD in 2005 and his MBA in 2016. Hovingh is an internist and vascular medicine specialist at the Department of Vascular Medicine at the Academic Medical Center (AMC) of the University of Amsterdam, the Netherlands and visiting professor at Imperial college in London, UK. Hovingh is head of the clinical trial unit and involved in a large number of clinical trials, mainly focused on novel therapies to combat (the consequences of) dyslipidemia. Hovingh gained his interest in genetic lipidology via research conducted at the AMC, and he co-authored over 170 publications (Hirsh factor: 38).
Through this research, Dr Hovingh has identified mutations in a large number of pivotal genes in lipid metabolism in patients with extreme dyslipidemia phenotypes. Overall aim of the unraveling of the molecular pathology in patients is to identify novel and innovative therapeutic pathways to reduce the burden of dyslipidemia and cardiovascular disease.
Mon 30 Nov
HoFH International Collaboration – HICC registry
4. Familial hypercholesterolaemia - Practice Essentials